fda semaglutide warning november 2025 Drug compounders sue over declaration ending Wegovy shortage With FDA approval of Wegovy

Recently, Novo has also undergone significant personnel changes, including Maziar Mike Doustdar succeeding Lars Fruergaard Jrgensen as president and CEO

Wegovy-related fatigue is often most pronounced during the initial dose escalation phase (first 1620 weeks) and typically improves as the body adapts to reduced caloric intake and metabolic changes

In addition, GLP-1 activation increases neogenesis and proliferation while decreasing apoptosis of pancreatic -cells (14)

In December 2025, the FDA approved a once-daily pill version of Wegovy

Here's the typical week-by-week breakdown: Most patients reach their maintenance dose of 2.4 mg by week 17